(Q44311944)

English

Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

urinary tract infection

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Dan C Henry

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Robert B Bettis

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ernie Riffer

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Daniel C Haverstock

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Steven F Kowalsky

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Kathryn Manning

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Deborah A Church

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2088-2104

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary tract infection: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and treatment of uncomplicated urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The ECO*SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic use and Escherichia coli resistance trends for quinolones and cotrimoxazole in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980099-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)80099-6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44311944&oldid=2109359662"